Our Services
Medical Information
Helpful Resources
Published on: 10/6/2026
Chemotherapy suppresses bone marrow and white blood cell production, which can leave the immune system less able to contain bacterial infections such as plague (Yersinia pestis) once exposure occurs, though it does not make initial exposure more likely. Exposure risk still depends mainly on contact with infected fleas, rodents, or respiratory droplets, while treatment-related neutropenia influences how quickly illness may progress and how urgently antibiotics are needed. Fever during or shortly after chemotherapy is always treated as an emergency, regardless of the suspected cause, and several additional factors are important to weigh, as explained in the complete answer below. Because symptoms like fever, chills, swollen lymph nodes, and fatigue overlap heavily with common chemotherapy side effects, sorting out what is happening on your own is difficult. A free, instant, online symptom check can help you organize your symptoms, understand which patterns deserve urgent attention, and decide on your next steps with more confidence.
Last reviewed for medical accuracy: 10/06/2026
Undergoing chemotherapy can weaken your immune system, but what does that mean for your risk of contracting plague? Below, we explore the relationship between chemotherapy and plague risk, explain the factors involved, and offer practical steps to stay safe.
Chemotherapy works by targeting rapidly dividing cells—including cancer cells. Unfortunately, some healthy cells in your bone marrow, gut and hair follicles also divide quickly. When these cells are damaged, your body’s ability to fight infections can drop. Key points:
“Plague” refers to infection by the bacterium Yersinia pestis. While most cases today occur in limited regions—parts of Africa, Madagascar, the western United States and Central Asia—understanding transmission is vital:
Chemotherapy itself does not create new ways to catch plague, but it can make an existing exposure more dangerous. Here’s how plague risk and chemotherapy intersect:
According to the U.S. Centers for Disease Control and Prevention (CDC) and World Health Organization (WHO):
Minimizing your plague risk involves general infection control plus specific steps for plague-prone areas. Consider these measures:
If plague is suspected in someone on chemotherapy:
Prompt medical attention can reduce fatality rates from around 50–60% (untreated) to less than 10% with timely treatment.
Facing both cancer and the possibility of a rare infection like plague can be unsettling. To keep anxiety in check:
If you’re on chemotherapy and concerned about possible infection—plague or otherwise—you don’t have to wait to act. You might consider doing a free, online symptom check, using the doctor approved Ubie Symptom Checker to help clarify your next steps.
Above all, if you experience any life-threatening or serious symptoms—fever above 100.4°F (38°C), severe headache, rapid breathing or unexplained swelling—speak to a doctor right away.
Chemotherapy can raise your plague risk by weakening your immune defenses, but informed precautions and rapid treatment dramatically reduce that risk. Stay vigilant, practice recommended safety measures and maintain open communication with your healthcare team. If in doubt, always reach out and speak to a doctor—your health depends on timely action.
(References)
* Osmon DR. Antimicrobial prophylaxis in adults. Mayo Clin Proc. 2000 Jan;75(1):98-109. doi: 10.4065/75.1.98. PMID: 10630764.
* Alpar HO, Eyles JE, Williamson ED, Somavarapu S. Intranasal vaccination against plague, tetanus and diphtheria. Adv Drug Deliv Rev. 2001 Sep 23;51(1-3):173-201. doi: 10.1016/s0169-409x(01)00166-1. PMID: 11516788.
* Woods TC, Marks AR. Drug-eluting stents. Annu Rev Med. 2004;55:169-78. doi: 10.1146/annurev.med.55.091902.105243. PMID: 14746515.
* El Kamar FG, Posner JB. Brain metastases. Semin Neurol. 2004 Dec;24(4):347-62. doi: 10.1055/s-2004-861530. PMID: 15637647.
* Poole K. Efflux-mediated antimicrobial resistance. J Antimicrob Chemother. 2005 Jul;56(1):20-51. doi: 10.1093/jac/dki171. Epub 2005 May 24. PMID: 15914491.
* Geller AI, Nopkhun W, Dows-Martinez MN, Strasser DC. Polypharmacy and the role of physical medicine and rehabilitation. PM R. 2012 Mar;4(3):198-219. doi: 10.1016/j.pmrj.2012.02.012. PMID: 22443958.
* Trepo C. A brief history of hepatitis milestones. Liver Int. 2014 Feb;34 Suppl 1:29-37. doi: 10.1111/liv.12409. PMID: 24373076.
* Kelly R, Houseknecht S. Considerations in the Care of Non-Small-Cell Lung Cancer: The Value Imperative. Oncology (Williston Park). 2018 Nov 15;32(11):534-40. PMID: 30474101.
* Malcolm DW, Wang Y, Overby C, Newman M, Benoit DSW. Delivery of RNAi-Based Therapeutics for Bone Regeneration. Curr Osteoporos Rep. 2020 Jun;18(3):312-324. doi: 10.1007/s11914-020-00587-2. PMID: 32394316; PMCID: PMC7322619.
* Randremanana RV, Raberahona M, Bourner J, Rajerison M, Edwards T, Randriamparany R, Fehizoro Razafindratsinana T, Razananaivo LH, Zadonirina G, Mayouya-Gamana T, Salam APA, Mangahasimbola RT, Andrianaivoarimanana V, Pesonel E, Rakotoarivelo RA, Randria MJD, Horby P, Olliaro P, IMASOY Study Group. Ciprofloxacin versus Aminoglycoside-Ciprofloxacin for Bubonic Plague. N Engl J Med. 2025 Aug 7;393(6):544-555. doi: 10.1056/NEJMoa2413772. PMID: 40768716; PMCID: PMC7618094.
We would love to help them too.
For First Time Users
We provide a database of explanations from real doctors on a range of medical topics. Get started by exploring our library of questions and topics you want to learn more about.
Was this page helpful?
Purpose and positioning of servicesUbie Doctor's Note is a service for informational purposes. The provision of information by physicians, medical professionals, etc. is not a medical treatment. If medical treatment is required, please consult your doctor or medical institution. We strive to provide reliable and accurate information, but we do not guarantee the completeness of the content. If you find any errors in the information, please contact us.